RU

Russia

6882 clinical trials

Find Trials

Clinical Trials (6882)

Showing 20 of 6,882 trialsScroll for more
NCT03765918Phase 33 sites

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

Active Not Recruiting
NCT03748641Phase 318 sites

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer

Active Not Recruiting
NCT02960022Phase 26 sites

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Recruiting
NCT05438043Phase 39 sites

A Study of Daratumumab

Active Not Recruiting
NCT05138133Phase 31 site

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Active Not Recruiting
NCT05179876Phase 35 sites

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Recruiting
NCT04640623Phase 29 sites

A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

Active Not Recruiting
NCT04175600Phase 36 sites

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Active Not Recruiting

A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

Active Not Recruiting
NCT02908906Phase 13 sites

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

Active Not Recruiting
NCT03383458Phase 34 sites

A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

Active Not Recruiting
NCT05669989Phase 22 sites

International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

Enrolling By Invitation
NCT04929210Phase 421 sites

A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

Active Not Recruiting
NCT01804686Phase 318 sites

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Recruiting
NCT04656652Phase 37 sites

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

Active Not Recruiting
NCT03767244Phase 37 sites

A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Active Not Recruiting
NCT04658862Phase 312 sites

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

Active Not Recruiting
NCT04544436Phase 314 sites

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

Active Not Recruiting
NCT03772990Phase 49 sites

Calcium Administration in Cardiac Surgery

Completed
NCT04678856Phase 24 sites

Dupilumab in CRSsNP

Completed